An observational study in Carbon Monoxide Poisoning, sponsored by Intermountain Health Care, Inc.. Enrolling by invitation at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-29.
Sponsored by Intermountain Health Care, Inc. · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Carbon Monoxide Poisoning with a site in United States — 2 open to participants now, 2 under way, none of them phase 3. Carbon Monoxide Poisoning · United States.
Among the 12 studies in Carbon Monoxide Poisoning with a site in United States, this one is the only one that started in 2012, is one of 8 observational ones, and was the 7th registered.
44 studies on the registry are indexed under Carbon Monoxide Poisoning; 8 are open to participants now.
Browse Carbon Monoxide Poisoning studies →2 of the 12 studies in Carbon Monoxide Poisoning with a site in United States are open now. Recruiting first, the newest first:
University of Nebraska · Sites in United States
Ages 19+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 4 Carbon Monoxide Poisoning studies recruiting now, 2 set no upper age limit and none stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2012.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 104 across 25 observational studies indexed under Carbon Monoxide Poisoning.
Median enrollment 58 across the 4 interventional studies, 60 across the 8 observational. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 12 have an industry lead sponsor. The 7 most frequent:
Intermountain Health Care, Inc. is the lead sponsor of 120 studies on the registry; 15 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 3 (33%) have results posted.
Intermountain Health Care, Inc. has 4 studies filed under Carbon Monoxide Poisoning — fewer than ten, so there is no comparison to draw.
1 of the studies in Carbon Monoxide Poisoning with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06574048University of NebraskaCarbon Monoxide Hyperbaric Oxygen With Steroid Therapy | 2027-07 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Carbon Monoxide Poisoning with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this biorepository is to collect blood from patients at the time of CO poisoning and at follow-up visits months to years later. These samples can be used in the future to learn more about how CO damages the heart and brain and whether blood tests could predict which patients will have problems after CO poisoning.
The investigators propose to establish a biorepository for storage of serum, plasma, and DNA collected from patients with carbon monoxide (CO) poisoning. Participants will also be evaluated for clinical outcome. The biorepository will include serum and plasma from CO-poisoned patients drawn at the time of injury as well as from blood drawn at clinical follow-up visits. The biorepository will also bank DNA from these participants.
These specimens can be analyzed in the future to elucidate potential inflammatory and immunological mechanisms that cause brain and heart damage and identify possible biological and genetic predictors of poor outcome.
Study population includes patients who present to LDS Hospital or Intermountain Medical Center with symptomatic carbon monoxide poisoning and documented exposure to carbon monoxide.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients with acute CO poisoning. Blood collection for biorepository only, no study intervention.
Other: No study intervention
There is no study-related intervention.
Biorepository for serum and plasma
Serum and plasma from blood collected within 24 hours of acute CO poisoning
Time frame: Within 24 hours of CO Poisoning
Serum and plasma (sub-acute)
Serum and plasma collected 4 weeks to 4 months after poisoning
Time frame: 4 weeks to 4 months after CO poisoning
DNA Sequestration
DNA sequestered from blood drawn up to 1 year from CO poisoning
Time frame: 24 hours to 12 months after CO poisoning
Serum and plasma (long-term)
Serum and plasma collected 4 months to 12 months after poisoning
Time frame: 4 months to 12 months after CO poisoning
Started Feb 2012 (actual). Primary completion is estimated for Dec 2032, 250 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intermountain Health Care, Inc. →